Comments
Pfizer/Bristol drug cuts recurrence of blood clots - study
09.12.2012. | (Reuters) - A new blood clot preventer from Pfizer Inc and Bristol-Myers Squibb Co reduced the risk of recurrence of clots in veins and lungs and death by 80 percent with no increase in major bleeding in a study testing extended use of the drug....
